QUARTA, SANTINA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.238
AS - Asia 2.856
EU - Europa 1.646
SA - Sud America 663
AF - Africa 587
OC - Oceania 63
Continente sconosciuto - Info sul continente non disponibili 20
Totale 11.073
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.946
SG - Singapore 1.078
CN - Cina 659
BR - Brasile 439
IT - Italia 280
HK - Hong Kong 266
DE - Germania 211
VN - Vietnam 210
FI - Finlandia 176
SE - Svezia 155
PL - Polonia 119
GB - Regno Unito 68
IN - India 67
RU - Federazione Russa 61
FR - Francia 55
NL - Olanda 53
UA - Ucraina 44
MX - Messico 42
AT - Austria 41
AR - Argentina 38
CA - Canada 34
ZA - Sudafrica 34
JP - Giappone 33
IE - Irlanda 29
MA - Marocco 29
EC - Ecuador 28
TR - Turchia 28
IQ - Iraq 26
PE - Perù 26
AE - Emirati Arabi Uniti 25
KR - Corea 25
PY - Paraguay 25
VE - Venezuela 25
CO - Colombia 24
MN - Mongolia 24
PK - Pakistan 24
UZ - Uzbekistan 24
ID - Indonesia 23
JO - Giordania 23
AO - Angola 22
ES - Italia 22
LY - Libia 22
CY - Cipro 21
AL - Albania 20
AZ - Azerbaigian 20
NI - Nicaragua 20
BB - Barbados 19
BF - Burkina Faso 19
CM - Camerun 19
IR - Iran 19
JM - Giamaica 19
BD - Bangladesh 18
CH - Svizzera 18
CI - Costa d'Avorio 18
LC - Santa Lucia 18
MY - Malesia 18
PA - Panama 18
UY - Uruguay 18
AU - Australia 17
CL - Cile 17
CZ - Repubblica Ceca 17
GH - Ghana 17
IS - Islanda 17
LB - Libano 17
SD - Sudan 17
BE - Belgio 16
BZ - Belize 16
DZ - Algeria 16
LA - Repubblica Popolare Democratica del Laos 16
ML - Mali 16
SN - Senegal 16
TH - Thailandia 16
BO - Bolivia 15
CG - Congo 15
DJ - Gibuti 15
EG - Egitto 15
GN - Guinea 15
KG - Kirghizistan 15
NE - Niger 15
SK - Slovacchia (Repubblica Slovacca) 15
TW - Taiwan 15
AD - Andorra 14
BJ - Benin 14
CR - Costa Rica 14
HR - Croazia 14
KZ - Kazakistan 14
LV - Lettonia 14
PH - Filippine 14
TZ - Tanzania 14
CU - Cuba 13
CV - Capo Verde 13
ET - Etiopia 13
GR - Grecia 13
IL - Israele 13
KH - Cambogia 13
ME - Montenegro 13
MG - Madagascar 13
NZ - Nuova Zelanda 13
PS - Palestinian Territory 13
PT - Portogallo 13
Totale 10.506
Salva come PNG Salva come JPEG
Città #
Singapore 617
Ashburn 518
Fairfield 502
Chandler 418
Woodbridge 283
Houston 248
Hong Kong 246
Jacksonville 231
Wilmington 231
Ann Arbor 220
Cambridge 195
Seattle 190
Santa Clara 161
Beijing 145
Boardman 131
Padova 105
Bytom 89
Helsinki 79
Princeton 79
Los Angeles 78
Des Moines 72
Ho Chi Minh City 69
Munich 69
San Jose 67
San Diego 66
Nanjing 64
New York 61
Medford 57
Hanoi 42
Dearborn 40
Hefei 39
São Paulo 39
Roxbury 35
Turku 35
Buffalo 26
Guangzhou 25
Nuremberg 25
Chicago 24
Shenyang 24
Amman 23
Dublin 23
Tashkent 23
Changsha 22
Ulan Bator 22
Warsaw 22
Stockholm 21
Tokyo 21
Baku 20
Brooklyn 20
Frankfurt am Main 20
Johannesburg 20
London 20
Luanda 19
Abidjan 18
Atlanta 18
Lima 18
Managua 18
Vienna 18
Panama City 17
Pune 17
Castries 16
Dakar 16
Denver 16
Orem 16
Accra 15
Bamako 15
Dallas 15
Dong Ket 15
Jinan 15
Phoenix 15
Andorra la Vella 14
Bridgetown 14
Jiaxing 14
Milan 14
Montevideo 14
Nanchang 14
Riga 14
The Dalles 14
Antananarivo 13
Bishkek 13
Chennai 13
Conakry 13
Djibouti 13
Kunming 13
Montreal 13
Ouagadougou 13
Reykjavik 13
Tripoli 13
Boston 12
Guayaquil 12
Hebei 12
Kampala 12
Kigali 12
Lusaka 12
Niamey 12
Phnom Penh 12
Podgorica 12
San Francisco 12
Tirana 12
Vientiane 12
Totale 6.605
Salva come PNG Salva come JPEG
Nome #
Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles 287
SCCA1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity 253
PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting 253
Synthesis, chemical characterization and cancer cell growth-inhibitory activities of Cu(ii) and Ru(iii) aliphatic and aromatic dithiocarbamato complexes 239
Low p66shc with high serpinb3 levels favors necroptosis and better survival in hepatocellular carcinoma 233
Biological and clinical implications of HBV infection in peripheral blood mononuclear cells 207
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 202
1-Piperidine Propionic Acid Protects from Septic Shock Through Protease Receptor 2 Inhibition 201
Au(III)-Proline derivatives exhibiting selective antiproliferative activity against HepG2/SB3 apoptosis-resistant cancer cells 199
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma 198
SERPINB3 induces epithelial-mesenchymal transition. 193
Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett's carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy 189
SERPINB3, apoptosis and autoimmunity 183
Re-programming pullulan for targeting and controlled release of doxorubicin to the hepatocellular carcinoma cells 180
Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis 178
Exogenous Administration of SERPINB3 Inhibits Cell Reprogramming 177
SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma 177
SERPINB3 INDUCES EPITHELIAL MESENCHYMAL TRANSITION 175
Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma 174
Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease 174
Hepatic progenitor cells express SerpinB3 171
Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice. 170
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 169
Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumour? 165
SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells 163
Biodistribution of Intratracheal, Intranasal, and Intravenous Injections of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles in a Mouse Model for Drug Delivery Studies 155
Labelled micelles for the delivery of cytotoxic Cu(II) and Ru(III) compounds in the treatment of aggressive orphan cancers: design and biological in vitro data 152
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma 150
Monitoring SCCA-IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis 146
HEPATIC PROGENITOR CELLS OVEREXPRESS SERPINB3 IN A MOUSE MODEL OF FULMINANT HEPATITIS 145
The Protease Activated Receptor 2 - CCAAT/Enhancer-Binding Protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of Non-Alcoholic Steatohepatitis 142
1-Piperidine Propionic Acid as an Allosteric Inhibitor of Protease Activated Receptor-2 136
Deregulation of Squamous Cell Carcinoma Antigen (SCCA) expression in B lymphocytes in patients with chronic hepatitis C 136
SERPINB3 AS A PRO-INFLAMMATORY MEDIATOR IN THE PROGRESSION OF EXPERIMENTAL NON-ALCOHOLIC FATTY LIVER DISEASE. 135
The polymorphic variant of SerpinB3 (SerpinB3-PD) is associated with faster cirrhosis decompensation 131
Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition 130
CARATTERIZZAZIONE BIOLOGICA E FUNZIONE DELLA NUOVA ISOFORMA SCCA-PD 130
Activation of pivotal cell cycle proteins and inhibition of apoptosis by SCCA1 in HepG2 cells 129
Monitoring SCCA-IgM complex predicts liver disease progression in patients with chronic hepatitis and cirrhosis 128
RUOLO DI SERPINB3 ELLA PROGRESSIONE DELLA MALATTIA EPATICA 125
Vescicole extracellulari da cellule geneticamente modificate iperesprimenti SerpinB3 per uso come agenti terapeutici 124
SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness 124
SERPINB3 INDUCES EPITHELIAL MESENCHYMAL TRANSITION 122
DEREGOLAZIONE DELL’ESPRESSIONE DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) NEI LINFOCITI B IN PAZIENTI INFETTI DA HCV 121
SCCA overexpression induces cell proliferation and down-regulation of the adhesion system 118
Semisolid Wet Sol–Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo 117
ESPRESSIONE DELLA SERPINA SCCA IN CELLULE MONONUCLEATE DI SANGUE PERIFERICO IN PAZIENTI CO INFEZIONE CRONICA DA HCV 117
SerpinB3/Protease Activated Receptor-2 Axis Is Essential for SARS CoV-2 Infection 116
SCCA EXPRESSION IN PBMCs IN PATIENTS WITH CHRONIC HEPATITIS C 116
Circulating Squamous Cell Carcinoma Antigen-IgM complexes as novel biomarkers for hepatocellular carcinoma 115
Espressione della serpina SCCA in cellule mononucleate di sangue periferico in pazienti con infezione cronica da HCV 115
POLIMORFISMO DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) E PROGRESSIONE DELLA MALATTIA EPATICA NELL’INFEZIOE HCV 115
SERPINB3 modulates TGF-beta expression in chronic liver disease. 113
HPYPOXYA UP-REGULATES SERPINB3 IN HEPATIC CANCER CELLS: A HIF-2a ASSOCIATED EVENT RELATED TO INVASIVENESS AND EPITHELIAL TO MESENCHYMAL TRANSITION 113
SQUAMOUS CELL CARCINOMA ANTIGEN (SCCA) ENHANCES LIVER REGENERATION AFTER PARTIAL HEPATECTOMY 113
SerpinB3 administration protects liver against ischemia-reperfusion injury 111
DOWNREGULATION OF SURFACE SQUAMOUS CELL CARCINOMA ANTIGEN EXPRESSION AND CD27+ MOLECULE ON B LYMPHOCYTES IN PATIENTS WITH CHRONIC HEPATITIS C 111
CHARACTERIZATION OF SCCA-1(SERPINB3) ISOFORMS IN HEPATOCELLULAR CARCINOMA 111
HYPOXIA UP-REGULATES SERPINB3 IN HEPG2 CELLS: A REDOX SENSITIVE EVENT RELATED TOEPITHELIAL TO MESENCHYMAL TRANSITIONAND INVASIVENESS 110
OVEREXPRESSION OF SERPINB3 IN HEPATIC PROGENITOR CELLS IN A MOUSE MODEL OF ACUTE LIVER INJURY 110
COMPORTAMENTO DI SCCA-IgM NEL SIERO DI BAMBINI HBeAg POSITIVI SEGUITI NEL TEMPO 109
HFE, TGF-BETA1 AND SQUAMOUS CELL CARCNOMA ANTIGEN-1 POLYMORPHISMS AND LIVER DISEASE STAGE IN CHRONIC HCV INFECTION 107
SERPINB3 PROMUOVE L’INVASIVITA’ CELLULARE 106
HCC invasiveness induced by SCCA is associated with nuclear beta-catenin accumulation 106
Squamous cell carcinoma antigen (SCCA) expression and CD27+ memory B lymphocytes in patients with chronic hepatitis C and systemic lupus erythematosus (SLE) 99
SCCA1-IGM AND SCCA2-IGM COMPARED WITH TOTAL SCCA-IGM FOR DIAGNOSIS OF HEPATOCELLULAR CARCINOMA 98
ESPRESSIONE DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) E CELLULE B DELLA MEMORIA IN CORSO DI INFEZIONE DA VIRUS DELL’EPATITE C 95
SEX DEPENDENT IL-6 DEREGULATION BY SERPINB3 IN A TRANSGENIC MOUSE MODEL 92
PRO-ONCOGENIC EFFECT OF SQUAMOUS CELL CARCINOMA ANTIGEN VIA WNT/BETA-CATENIN SIGNALING 92
Inhibition of Protease-Activated Receptor-2 Activation in Parkinson’s Disease Using 1-Piperidin Propionic Acid 90
ESPRESSIONE DI TGF-b1 NELLA MALATTIA EPATICA EVOLUTIVA 90
SERPINB3 AND TGF-BETA IN CHRONIC LIVER DISEASE 89
Serum SCCA IgM complexes increase over time and HCC development in cirrhotic patients 88
CELLULE PROGENITRICI EPATICHE ESPRIMONO SERPINB3 IN UN MODELLO MURINO DI EPATITE FULMINANTE 84
SERPINB3 UP-REGULATION BY HYPOXIA IN HEPG2 CELLS : A HIF-2ALPHA AND REDOX SENSITIVE EVENT RELATED TO INVASIVENESS AND EPITHELIAL TO MESENCHYMAL TRANSITION 82
SERPINB3 AND TGF-BETA1 CORRELATION IN CHRONIC LIVER DISEASE OF VIRAL ETIOLOGY 77
MODULAZIONE DEI LIVELLI DI IL-6 NELLA RIGENERAZIONE EPATICA DA PARTE DI SERPINB3 ED ESTROGENI. ANALISI IN UN MODELLO DI TOPO TRANSGENICO 77
A New Assay for Quantitative Determination of Pres1-Encoded Protein in Patients Infected with Hepatitis B and Delta Viruses 73
Hepatotropic viruses: new insights in pathogenesis and treatment 71
SERPINB3 AND TGF-BETA1 CORRELATION IN CHRONIC LIVER DISEASE 69
The impact of serpinB3-PD polymorphism on the prognosis of patients with hepatocellular carcinoma 31
Totale 11.117
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.812
article - articoli 27.413
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 343
selected - selezionate 0
volume - volumi 0
Totale 61.568
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021531 0 0 0 0 0 0 20 39 101 173 98 100
2021/2022711 19 103 79 58 27 47 32 64 33 9 81 159
2022/2023885 140 88 18 96 153 146 0 79 107 6 38 14
2023/2024457 14 65 67 29 49 67 39 17 10 18 35 47
2024/20252.104 10 202 75 99 212 67 89 130 152 99 413 556
2025/20264.343 402 676 970 1.001 819 354 121 0 0 0 0 0
Totale 11.117